Short answer
Incyte (INCY) filed an 8-K current report with the SEC on June 8, 2026 reporting Item 8.01 (Other Events). Definitive agreement to acquire Vega Therapeutics, a Star Therapeutics subsidiary.
Incyte 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Definitive agreement to acquire Vega Therapeutics, a Star Therapeutics subsidiary
- Transaction expands Incyte’s pipeline through acquisition of Vega’s assets and capabilities
- Deal terms and expected financial impact require review of Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Incyte 8-K filings
Get the next INCY 8-K as it lands
Follow INCY for push alerts, or ask the research agent what this filing means.